Mechanisms of diabetes mellitus induced with FK506 in SD rats models

Immunopharmacology and Immunotoxicology

Volumn 31, Issue 4, 2009, Pages 675-681

  Li, Qing Yuan ^a   Li, Feng ^a   Sun, Ji Hua ^a   Chi, Yu You ^a   Yin, Hong Shan ^a   Qing Liu, Shao ^a   Mei, Yan Hui ^a  

^a Binzhou Medical University   (China)

Author keywords

Apoptosis; C peptide; Insulin; Insulin receptor; Tacrolimus; Ultra structure

Indexed keywords

C PEPTIDE; GLUCOSE; INSULIN; INSULIN RECEPTOR; TACROLIMUS;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL ULTRASTRUCTURE; CONTROLLED STUDY; DIABETES MELLITUS; DIABETOGENESIS; GLUCOSE BLOOD LEVEL; INSULIN BLOOD LEVEL; LIVER CELL; MALE; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RAT; SECRETORY GRANULE;

ANIMALS; DIABETES MELLITUS, EXPERIMENTAL; DISEASE MODELS, ANIMAL; INSULIN; INSULIN ANTAGONISTS; ISLETS OF LANGERHANS; MALE; RATS; RATS, SPRAGUE-DAWLEY; TACROLIMUS;

RATTUS;

EID: 70449132578     PISSN: 08923973     EISSN: 15322513     Source Type: Journal    
DOI: 10.3109/08923970903032747     Document Type: Article

References (35)

1. Antignac, M., Barrou, B., Farinotti, R., et al. Population pharmacokinetics and bioavailability of tacrolimus in kidney transplant patients. Br J. Clin. Pharmacol. 2007, 64(6),750-757
2. Blanchet, B., Duvoux, C., Costentin, C.E., et al. Pharmacokineticpharmacodynamic assessment of tacrolimus in liver-transplant recipients during the early post-transplantation period. Ther. Drug Monit. 2008, 30(4),412-418
3. Patel, J.K., Kobashigawa, J.A. Tacrolimus in heart transplant recipients: An overview. BioDrugs 2007, 21(3),139-143
4. Hachem, R.R., Yusen, R.D., Chakinala, M.M., et al. A randomized controlled trial of tacrolimus versus cyclosporine after lung transplantation. J. Heart Lung Transplant. 2007, 26(10),1012-1018
5. Rossetti, M., Piccoli, G.B., Burdese, M., et al. Tailored immunosuppression and steroid withdrawal in pancreas-kidney transplantation. Rev. Diabet. Stud. 2004, 1(3),129-136
6. Watts, A.B., Williams, R.O. 3rd., Peters, J.I. Recent developments in drug delivery to prolong allograft survival in lung transplant patients. Drug Dev. Ind. Pharm. 2008, 16,1-13.
7. Kuypers, D.R. Benefit-risk assessment of sirolimus in renal transplantation. Drug Saf. 2005, 28(2),153-181
8. Chamienia, A., Biedunkiewicz, B., Król, E., et al. One-year observation of kidney allograft recipients converted from cyclosporine microemulsion to tacrolimus. Transplant Proc. 2006, 38(1),81-85
9. Nielsen, F.T., Leyssac, P.P., Kemp, E., et al. Nephrotoxity of FK 506: A preliminary study on comparative aspects of FK 506 and cyclosporine nephrotoxicity. Transplant Proc. 1994, 26(6),3104-3105
10. Oztürk, S., Ayna, T.K., Cefle, K., et al. Effect of cyclosporin A and tacrolimus on sister chromatid exchange frequency in renal transplant patients. Genet. Test. 2008, 12(3),427-430
11. Vivarelli, M., Cucchetti, A., La Barba, G.,et al. Liver transplantation for hepatocellular carcinoma under calcineurin inhibitors: Reassessment of risk factors for tumor recurrence. Ann. Surg. 2008, 248(5),857-862
12. Shimizu, T., Ishida, H., Shirakawa, H., et al. Clinical and histological analysis of chronic tacrolimus nephrotoxicity in renal allografts. Transplant Proc. 2008, 40(7),2370-2372
13. Mazali, F.C., Lalli, C.A., Alves-Filho, G., et al. Posttransplant diabetes mellitus: Incidence and risk factors. Transplant Proc. 2008, 40(3),764-766
14. Sharma, A., Minz, M., Singh, S. et al. Incidence of glucose metabolic abnormalities in Indian living renal allograft recipients on tacrolimus-based triple drug immunosuppression. Transplant Proc. 2008, 40(7),2414-2415
15. Uchizono, Y., Iwase, M., Nakamura, U., et al. Tacrolimus impairment of insulin secretion in isolated rat islets occurs at multiple distal sites in stimulus-secretion coupling. Endocrinology 2004, 145(5),2264-2272
16. Gelens, M.A., Christiaans, M.H., van Hooff, J.P., Glucose metabolism before and after conversion from cyclosporine microemulsion to tacrolimus in stable renal recipients. Nephrol. Dial. Transplant. 2008, 23(2),701-706 Epub 2007 No.
17. Kanzler, S., Lohse, A.W., Schirmacher, P., et al. Complete reversal of FK 506 induced diabetes in a liver transplant recipient by change of immunosuppression to cyclosporine A. Z. Gastroenterol. 1996, 34(2),128-131
18. Bloom, R.D., Crutchlow, M.F. Transplant-associated hyperglycemia. Transplant Rev. (Orlando). 2008, 22(1),39-51.
19. Christiansen, E. [Posttransplant diabetes. Metabolic consequences of posttransplant immunosuppressive treatment] Ugeskr Laeger. 2007, 169(24),2309-2311
20. Dumler, F., Kilates, C. Metabolic and nutritional complications of renal transplantation. J. Ren. Nutr. 2007, 17(1),97-102.
21. Mannon, R.B. Therapeutic management of posttransplant diabetes mellitus. Transplant Rev. (Orlando) 2008, 22(2),116-124
22. Salifu, M.O., Tedla, F., Aytug, S., et al. Posttransplant diabetes and hypertension: Pathophysiologic insights and therapeutic rationale. Curr. Diab. Rep. 2008, 8(3),221-227
23. Tuerk, T.R., Bandur, S., Nuernberger, J., et al. Gliquidone therapy of new-onset diabetes mellitus after kidney transplantation. Clin. Nephrol. 2008, 70(1),26-32.
24. Rodrigo, E., Fernández-Fresnedo, G., Valero, R., et al. Newonset diabetes after kidney transplantation: Risk factors. J. Am. Soc. Nephrol. 2006, 17(12 Suppl 3),S291-S295.
25. Chien, Y.S., Chen, Y.T., Chuang, C.H., et al. Incidence and risk factors of new-onset diabetes mellitus after renal transplantation. Transplant. Proc. 2008, 40(7),2409-2411
26. Luan, F.L., Zhang, H., Schaubel, D.E., et al. Comparative risk of impaired glucose metabolism associated with cyclosporine versus tacrolimus in the late posttransplant period. Am. J. Transplant. 2008, 8(9),1871-1877
27. Shehab-Eldin, W., Shoker, A. Predictors of new onset of diabetes after transplantation in stable renal recipients. Nephron. Clin. Pract. 2008,110(1),c1-9. Epub 2008 Jul 24.
28. Veroux, M., Corona, D., Giuffrida, G., et al. New-onset diabetes mellitus after kidney transplantation: The role of immunosuppression. Transplant. Proc. 2008, 40(6),1885-1887
29. Johnston, O., Rose, C.L., Webster, A.C., et al. Sirolimus is associated with new-onset diabetes in kidney transplant recipients. J. Am. Soc. Nephrol. 2008, 19(7),1411-1418
30. Saboo, D., Shah, P.R., Goplani, K.R., et al. Posttransplant diabetes mellitus: A single-center study. Transplant. Proc. 2008, 40(4),1111-1113
31. Marcén, R., Morales, J.M., del Castillo, D., et al. Posttransplant diabetes mellitus in renal allograft recipients: A prospective multicenter study at 2 years. Transplant. Proc. 2006, 38(10),3530-3532
32. Sulanc, E., Lane, J.T., Puumala, S.E., et al. New-onset diabetes after kidney transplantation: An application of 2003 International Guidelines. Transplantation 2005, 15,80(7), 945-952
33. Wyzga?, J., Paczek, L., Sañko-Resmer, J., et al. Insulin resistance in kidney allograft recipients treated with calcineurin inhibitors. Ann. Transplant. 2007, 12(2),26-29
34. Drachenberg, C.B., Klassen, D.K., et al. Islet cell damage associated with tacrolimus and cyclosporine: Morphological features in pancreas allograft biopsies and clinical correlation. Transplantation 1999, 68(3),396-402.
35. Kohda, Y., Shirakawa, H., Yamane, K., et al. Prevention of incipient diabetic cardiomyopathy by high-dose thiamine. J. Toxicol. Sci. 2008, 33(4),459-472